Pharmos(PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: wolfdog2 who wrote (1136)	8/10/1998 8:54:00 PM
From: David Israel-Rosen	Read Replies (5) of 1491

Hello Everyone: I would like to comment about the issue of lack of Corporate Strategy of Pharmos. If I understand it correctly PARS strategy is as follows: 1) leverage DISCOVERY, Research and Development Expertise in Israel while leaving the followings to others: Sales and Marketing large scale clinical Trials 2) The company focuses (because of strategic or accidental reasons) on three areas of Drug Research and Development: Eyecare (2 approved Rx with 3rd forthcoming) Trauma, stroke etc (HU211) Cancer 3) The strategy is to leverage the 40+ PARS employees and deliver as much as possible output out of these 3 areas. 4) The CURRENT test is tactical. It requires execution and MUCH luck but not much else... 5) If HU211 is as big as we Hope it is, we are looking at a Billion $ Valuation real soon. If it is not...I do not know 6) Market price always catches up with Reality. The strategy is in place all is left is to execute and... 7) Pray. Nice to be back. Good luck to all David

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next